Explore the categories so you can find more about your search.

Categorie > Parkinson's Disease

UCB Announces The U.S. Launch Of Neupro (Rotigotine Transdermal System) For The Treatment Of Early-Stage Parkinson's Disease

Categorie : Parkinson's Disease
UCB and SCHWARZ PHARMA announced that Neupro (Rotigotine Transdermal System), a new once-daily transdermal dopamine agonist approved for the treatment of the signs and symptoms of early-stage idiopathic Parkinson's disease, is now commercially available in retail pharmacies throughout the Un ...

read more UCB and SCHWARZ PHARMA announced that Neupro (Rotigotine Transdermal System), a new once-daily transdermal dopamine agonist approved for the treatment of the signs and symptoms of early-stage idiopathic Parkinson's disease, is now commercially available in retail pharmacies throughout the Un read more Sun Oct 2007 Sun Oct 2007

Patient Enrollment On Target In National Institutes Of Health Phase III Parkinson's Disease Trial

Categorie : Parkinson's Disease
Avicena Group, Inc. (OTC Bulletin Board: AVGO), a late stage biotechnology company that develops central nervous system therapeutics for neurodegenerative diseases, announced today that the Phase III efficacy trial of the Company's lead Parkinson's disease drug candidate, PD-02, has enrolled 288 ...

read more Avicena Group, Inc. (OTC Bulletin Board: AVGO), a late stage biotechnology company that develops central nervous system therapeutics for neurodegenerative diseases, announced today that the Phase III efficacy trial of the Company's lead Parkinson's disease drug candidate, PD-02, has enrolled 288 read more Sun Oct 2007 Sun Oct 2007

FDA Approves New Dosage Strength Of Stalevo(R) For People With Parkinsons

Categorie : Parkinson's Disease
Novartis Pharmaceuticals Corporation announced that the U.S. Food and Drug Administration (FDA) has approved a new higher dose strength of Stalevo(R) (carbidopa, levodopa and entacapone) which is indicated for Parkinson's disease patients with signs and symptoms of end-of-dose "wearing off. ...

read more Novartis Pharmaceuticals Corporation announced that the U.S. Food and Drug Administration (FDA) has approved a new higher dose strength of Stalevo(R) (carbidopa, levodopa and entacapone) which is indicated for Parkinson's disease patients with signs and symptoms of end-of-dose read more Sun Oct 2007 Sun Oct 2007

New Parkinson's Disease Online Resource Now Available

Categorie : Parkinson's Disease
Consumers searching for information on Parkinson's disease, a progressive neurological condition that affects more than 1.5 million Americans, now have a new online destination. The Parkinson's Disease Blog Network (http://www.parkinsonsblognetwork.com) is the first site to centralize these individu ...

read more Consumers searching for information on Parkinson's disease, a progressive neurological condition that affects more than 1.5 million Americans, now have a new online destination. The Parkinson's Disease Blog Network (http://www.parkinsonsblognetwork.com) is the first site to centralize these individu read more Sun Oct 2007 Sun Oct 2007

Investigating The Causes Of Parkinson's Disease

Categorie : Parkinson's Disease
A University of Nottingham researcher has been awarded more than £440,000 by the Parkinson's Disease Society (PDS) to investigate the causes of the condition. Dr Lynn Bedford, of the School of Biomedical Sciences, will lead a five-year study after receiving an award from the PDS under ...

read more A University of Nottingham researcher has been awarded more than £440,000 by the Parkinson's Disease Society (PDS) to investigate the causes of the condition. Dr Lynn Bedford, of the School of Biomedical Sciences, will lead a five-year study after receiving an award from the PDS under read more Sun Oct 2007 Sun Oct 2007

Early Recognition Of Parkinson's Disease

Categorie : Parkinson's Disease
Specialists of the brain investigation department of the Scientific Research Institute of Neurology, Russian Academy of Medical Sciences, are developing methods for early pre-clinical recognition of Parkinson's disease. The method is based on the fact that even at early stages of the disease, th ...

read more Specialists of the brain investigation department of the Scientific Research Institute of Neurology, Russian Academy of Medical Sciences, are developing methods for early pre-clinical recognition of Parkinson's disease. The method is based on the fact that even at early stages of the disease, th read more Sun Oct 2007 Sun Oct 2007

Developing Methods To Separate The Brain's Good And Bad Iron To Combat Parkinson's And Alzheimer's

Categorie : Parkinson's Disease
Duke University chemists are developing ways to bind up iron in the brain to combat the neurological devastation of Parkinson's and Alzheimer's diseases. The key is to weed out potentially destructive forms of iron that generate harmful free radicals while leaving benign forms of iron alone to carry ...

read more Duke University chemists are developing ways to bind up iron in the brain to combat the neurological devastation of Parkinson's and Alzheimer's diseases. The key is to weed out potentially destructive forms of iron that generate harmful free radicals while leaving benign forms of iron alone to carry read more Sun Oct 2007 Sun Oct 2007

Michael J. Fox Foundation And New York Academy Of Sciences To Host First Major Parkinson's Drug Development Conference

Categorie : Parkinson's Disease
The Michael J. Fox Foundation for Parkinson's Research (MJFF) and The New York Academy of Sciences will co-host the inaugural PD Therapeutics Conference on Thursday, October 25, in New York City. This meeting is the first and only major scientific symposium exclusively focused on the development ...

read more The Michael J. Fox Foundation for Parkinson's Research (MJFF) and The New York Academy of Sciences will co-host the inaugural PD Therapeutics Conference on Thursday, October 25, in New York City. This meeting is the first and only major scientific symposium exclusively focused on the development read more Sun Oct 2007 Sun Oct 2007

Understanding The Impact Of Disclosing Genetic Test Results To Children

Categorie : Parkinson's Disease
Predictive genetic testing for adult-onset diseases, including cancer, is generally discouraged until the age at which interventions are believed to be helpful. Yet, many children of BRCA mutation carriers learn of their parents' genetic test results many years before preventive interventions ar ...

read more Predictive genetic testing for adult-onset diseases, including cancer, is generally discouraged until the age at which interventions are believed to be helpful. Yet, many children of BRCA mutation carriers learn of their parents' genetic test results many years before preventive interventions ar read more Sun Oct 2007 Sun Oct 2007

Loss Of 2 Types Of Neurons Implicated In Onset Of Parkinson's Symptoms

Categorie : Parkinson's Disease
New evidence indicates that the loss of two types of brain cells--not just one as previously thought--may trigger the onset of symptoms associated with Parkinson's disease.The evidence, based on mouse models, shows a link between the loss of both norepinephrine and dopamine neurons a ...

read more New evidence indicates that the loss of two types of brain cells--not just one as previously thought--may trigger the onset of symptoms associated with Parkinson's disease.The evidence, based on mouse models, shows a link between the loss of both norepinephrine and dopamine neurons a read more Sun Oct 2007 Sun Oct 2007

Sixty One Percent Of Newly Diagnosed Parkinson's Disease Patients Do Not Receive Any Drug Treatment In The First Year Of Diagnosis

Categorie : Parkinson's Disease
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that 61 percent of newly diagnosed Parkinson's disease patients do not receive any drug treatment in the first year of diagnosis. [click link for full article] ...

read more Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that 61 percent of newly diagnosed Parkinson's disease patients do not receive any drug treatment in the first year of diagnosis. [click link for full article] read more Sun Oct 2007 Sun Oct 2007

Scientists Spot Sneaky "Neurodegenerative" Iron At The European Synchrotron

Categorie : Parkinson's Disease
Scientists suspect that iron accumulation plays a role in neurodegenerative processes such as Parkinson's disease, but its distribution in neurons has never been observed because of the lack of techniques to do so. Until today. [click link for full article] ...

read more Scientists suspect that iron accumulation plays a role in neurodegenerative processes such as Parkinson's disease, but its distribution in neurons has never been observed because of the lack of techniques to do so. Until today. [click link for full article] read more Sun Oct 2007 Sun Oct 2007

Decline In Testosterone May Contribute To Cognitive Impairment, Brain Disorders And Neuron Death

Categorie : Parkinson's Disease
A remarkable change takes place in the brains of tiny songbirds every year, and some day the mechanism controlling that change may help researchers develop treatments for age-related degenerative diseases of the brain such as Parkinson's and dementia. [click link for full article] ...

read more A remarkable change takes place in the brains of tiny songbirds every year, and some day the mechanism controlling that change may help researchers develop treatments for age-related degenerative diseases of the brain such as Parkinson's and dementia. [click link for full article] read more Sun Oct 2007 Sun Oct 2007

Gene Abnormality Tied To Getting Parkinson's Disease At A Younger Age

Categorie : Parkinson's Disease
People with a certain gene mutation are more likely to get Parkinson's disease before the age of 50 compared to those without the gene abnormality, according to a study published in the September 18, 2007, issue of Neurology, the medical journal of the American Academy of Neurology. For the study, r ...

read more People with a certain gene mutation are more likely to get Parkinson's disease before the age of 50 compared to those without the gene abnormality, according to a study published in the September 18, 2007, issue of Neurology, the medical journal of the American Academy of Neurology. For the study, r read more Sun Oct 2007 Sun Oct 2007

PRODEST Study Shows Many Parkinson's Disease (PD) Patients Continue To Experience Symptoms Despite Receiving Anti-depressant Treatment

Categorie : Parkinson's Disease
Preliminary results of the pan-European PRODEST study in 1016 patients with Parkinson`s disease (PD) were presented at the 11th Congress of the European Federation of Neurological Societies (EFNS) in Brussels this week, revealing unique features of PD-related depression and its treatment.1 T ...

read more Preliminary results of the pan-European PRODEST study in 1016 patients with Parkinson`s disease (PD) were presented at the 11th Congress of the European Federation of Neurological Societies (EFNS) in Brussels this week, revealing unique features of PD-related depression and its treatment.1 T read more Sun Oct 2007 Sun Oct 2007

Many Parkinson's Disease Patients Continue To Experience PD-Related Depressive Symptoms Despite Receiving Anti-Depressant Treatment

Categorie : Parkinson's Disease
Preliminary results of the pan- European PRODEST study in 1016 patients with Parkinson's disease (PD) were presented at the 11th Congress of the European Federation of Neurological Societies (EFNS) in Brussels this week, revealing unique features of PD-related depression and its treatment.1 ...

read more Preliminary results of the pan- European PRODEST study in 1016 patients with Parkinson's disease (PD) were presented at the 11th Congress of the European Federation of Neurological Societies (EFNS) in Brussels this week, revealing unique features of PD-related depression and its treatment.1 read more Sun Oct 2007 Sun Oct 2007

Neupro Effective In Controlling Early Morning Motor Impairment And Generally Well-Tolerated For Long-Term Use In Patients With Parkinson's Disease

Categorie : Parkinson's Disease
UCB, Inc. presented data from two clinical trials that showed Neupro® (Rotigotine Transdermal System), a once-daily non-ergolinic dopamine agonist patch, is effective in controlling early morning motor impairment, provides improvement in sleep quality, and is generally well-tolerate ...

read more UCB, Inc. presented data from two clinical trials that showed Neupro® (Rotigotine Transdermal System), a once-daily non-ergolinic dopamine agonist patch, is effective in controlling early morning motor impairment, provides improvement in sleep quality, and is generally well-tolerate read more Sun Oct 2007 Sun Oct 2007

American And European Parkinson's Sufferers Find Chinese Stem Cell Treatment Effective, Proving Western Debates Moot

Categorie : Parkinson's Disease
Tiantan Puhua Neurosurgical Hospital, the world's leading center for effective treatment of Parkinson's disease using adult retinal stem cells, here announced that four more international patients returned home from China with a significant reduction in their debilitating Parkinson's dise ...

read more Tiantan Puhua Neurosurgical Hospital, the world's leading center for effective treatment of Parkinson's disease using adult retinal stem cells, here announced that four more international patients returned home from China with a significant reduction in their debilitating Parkinson's dise read more Sun Oct 2007 Sun Oct 2007

Gene That Lowers Cell Stress Could Protect Against Parkinson's Disease, UK

Categorie : Parkinson's Disease
The discovery of a relationship between two cell enzymes and their role in keeping the cell's energy generating machinery working smoothly could provide a new target for development of therapies for Parkinson's disease (PD). Research led by Dr L. [click link for full article] ...

read more The discovery of a relationship between two cell enzymes and their role in keeping the cell's energy generating machinery working smoothly could provide a new target for development of therapies for Parkinson's disease (PD). Research led by Dr L. [click link for full article] read more Sun Oct 2007 Sun Oct 2007

Parkinson's Volunteers Sought For Speech Study, Australia

Categorie : Parkinson's Disease
UQ researchers are seeking volunteers diagnosed with Parkinson's disease, and who have difficulty with their speech, to participate in a project. The School of Health and Rehabilitation Sciences project will examine lip, tongue, and jaw function in individuals with speech difficulties as a result of ...

read more UQ researchers are seeking volunteers diagnosed with Parkinson's disease, and who have difficulty with their speech, to participate in a project. The School of Health and Rehabilitation Sciences project will examine lip, tongue, and jaw function in individuals with speech difficulties as a result of read more Sun Oct 2007 Sun Oct 2007

1 | 2 | 3 | 4 next >>>



     


Custom Search